🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose is to demonstrate the bioequivalence of naproxen admini...
Status
Completed
Location
Research Site
Start Date
2011-09
Trial ID
NCT01331993
Treatments Being Tested
D.R.E.A.M.S. will assess an immersive digital reality-augmenting system in ...
Status
Active Not Recruiting
Location
UF Health
Start Date
2018-01-16
Trial ID
NCT03385993
Treatments Being Tested
The primary purpose of the study is to test the efficacy of 2 tablets (twic...
Status
Completed
Location
Site Reference ID/Investigator# 10044
Start Date
2008-09
Trial ID
NCT00763321
This is an open-label,single arm,Phase Ib study,in order to evaluate the sa...
Status
Terminated
Location
The First Affiliated Hospital of Guangxi Medical University
Start Date
2022-06-10
Trial ID
NCT04941404
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
The overall goal of this exploratory proof-of-concept study is to determine...
Status
Completed
Location
Task Applied Science and Stellenbosch University
Start Date
2017-08-23
Trial ID
NCT03174184
The primary purpose of this study is to compare the plasma pharmacokinetics...
Status
Completed
Location
Orlando Clinical Research Center ( Site 0001)
Start Date
2022-06-24
Trial ID
NCT04995484
Treatments Being Tested
In the context of the accelerating aging population and the continuous decl...
Status
Recruiting
Location
Beijing Obstetrics and Gynecology Hospital,Capital Medical University
Start Date
2025-03-17
Trial ID
NCT06794047
The purpose of this study is to evaluate and compare the efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00276458
Treatments Being Tested
This is a phase 2 randomized, placebo-controlled, double-blind, parallel-gr...
Status
Completed
Location
Axis Clinical Trials
Start Date
2019-08-14
Trial ID
NCT03861143
Treatments Being Tested